
A Dubai shipment of abiraterone acetate tablets needs more than an invoice and an airway bill. You need to identify the import route, separate customs papers from medicine-approval documents, and reconcile every product and batch detail before dispatch. By the end, you will have a route-specific checklist for checking the supplier, UAE consignee, shipment and regulatory file.
Key takeaways
- Confirm the UAE-licensed importer and approval route before requesting supplier documents.
- Create separate customs-clearance and medicine-approval document files.
- Match strength, pack size, batch number and expiry across every document.
- Verify the Indian supplier’s licences and legalise only documents the route requires.
Confirm the Dubai import route before requesting documents
A Dubai buyer must identify the Dubai import route before requesting supplier paperwork. Confirm the exact abiraterone acetate product, 250 mg or 500 mg strength, manufacturer and pack size, then ask the UAE-licensed importer which authority will approve it. A supplier’s Indian licence does not authorise commercial sale in Dubai.
| Route | Primary authority or pathway | Confirm before requesting documents |
|---|---|---|
| Registered commercial supply | MOHAP medicines registration and import pathway, through a UAE-licensed marketing-authorisation holder or importer | The product is registered or otherwise approved for import and the importer can obtain the required permit |
| Dubai hospital, clinic or health-facility supply | DHA-licensed facility or procurement route, with medicine approval requirements confirmed with MOHAP or the competent authority | The consignee’s DHA licence, facility use and purchasing authority cover this product |
| Named-patient, special access or re-export | Special-import or re-export pathway confirmed by the importer with MOHAP, DHA where relevant, and customs | The patient, facility, destination market and supporting approval match the shipment |
Dubai Customs handles the customs declaration and release of the consignment; it does not replace medicine registration or an import approval. The airway bill or bill of lading, commercial invoice, packing list, certificate of origin and customs declarations support clearance after regulatory eligibility is established.
Also obtain written confirmation of the minimum remaining shelf life accepted for this route. Do not accept a universal percentage or month promise, because the rule can apply at arrival or clearance and vary by authority or product category.
Verify that abiraterone is treated under the correct prescription or special-import classification, not as a narcotic solely because it is an oncology medicine.
Build two files: customs clearance and medicine approval
Collect two separate files: a customs-clearance file and a medicine-approval and procurement file. Keeping them separate prevents an airway bill or customs declaration from being mistaken for permission to import a prescription oncology medicine.
Customs-clearance file:
- Commercial invoice naming abiraterone acetate, the 250 mg or 500 mg tablet strength, dosage form, pack size, quantity, value, manufacturer and country of origin.
- Packing list showing cartons, packs, gross and net weight, batch numbers, manufacturing dates and expiry dates.
- Certificate of origin issued for the shipment.
- Airway bill or bill of lading.
- Export declaration and any Dubai Customs entry documents.
- UAE consignee’s trade licence, importer code and pharmaceutical trading or distribution licence.
Medicine-approval and procurement file:
- UAE product registration or eligibility evidence from the authority handling the route, such as MOHAP or DHA.
- Import approval or special-import authorisation for an unregistered product, named patient, hospital, clinic or re-export shipment.
- Manufacturer’s licence, product authorisation evidence and batch-specific Certificate of Analysis.
- Purchase order, supply agreement and end-use statement identifying the licensed buyer.
| File | Core question | Evidence |
|---|---|---|
| Customs clearance | Can the shipment enter Dubai? | Invoice, packing list, origin certificate, transport document, declarations and importer credentials |
| Medicine approval and procurement | Is this product eligible and properly sourced? | Registration or import approval, manufacturer evidence, batch Certificate of Analysis and purchase records |
Check that every file uses “abiraterone acetate,” the same tablet strength, manufacturer, pack configuration and batch details. A generic specification without the shipped batch number is not a batch-release document.
Reconcile the invoice, carton, blister and batch certificate
Do not approve dispatch until every document and physical pack identifies the same saleable product. A single mismatch in strength, batch number or pack size can trigger a Dubai Customs query, a regulatory hold or a request for replacement paperwork.
1. Copy the invoice and packing-list entries into a comparison sheet. Match the exact product name “abiraterone acetate,” tablet form, 250 mg or 500 mg strength, pack configuration, number of packs, manufacturer, country of origin, gross weight and net weight.
2. Read one carton and one blister from the shipment. Check that both show the same product name, strength, manufacturer, batch number, manufacturing date and expiry date recorded on the invoice and packing list. Do not treat “abiraterone” as an acceptable substitute for “abiraterone acetate.”
3. Match the batch number, manufacturing date and expiry date against the batch-specific certificate of analysis. Confirm that it reports test specifications, actual results and the named pharmacopoeial or approved in-house methods; a generic product specification is not sufficient.
4. Request the batch-release certificate from the manufacturer’s responsible quality unit and compare its product description, strength and batch number with the other records. A certificate of analysis reports test results; it does not by itself prove formal batch release.
5. Ask the supplier to correct discrepancies before booking air freight or sea freight. Recheck the corrected invoice, packing list, certificate of origin and airway bill or bill of lading against the final cartons. Keep dated copies for the UAE importer’s approval and customs file.
Check strength, artwork, shelf life and transport conditions
Do not treat 250 mg and 500 mg as interchangeable entries. Verify the exact product registration or importability in the UAE for each strength, manufacturer, dosage form and pack size. A supplier’s Indian licence does not prove that either presentation has a UAE marketing authorisation or an approved import route.
| Pack | Entries that must match |
|---|---|
| abiraterone acetate 250 mg | Product name, 250 mg strength, tablets, manufacturer, pack size, batch and expiry |
| abiraterone acetate 500 mg | Product name, 500 mg strength, tablets, manufacturer, pack size, batch and expiry |
Before payment, check the proposed artwork against the approved label and leaflet. Look for “abiraterone acetate,” not merely “abiraterone,” plus the tablet strength, excipients, storage statement, manufacturer, batch fields, expiry format and UAE importer or registration details. Different manufacturers can use different coatings, tablet colours, excipients and blister materials.
- Match the invoice, packing list, carton, blister, certificate of analysis and batch-release document to the same strength, batch number, manufacturing date, expiry date and quantity.
- Obtain the approved artwork, product licence or marketing authorisation, and evidence of product registration for the exact presentation.
- Confirm the minimum remaining shelf life accepted by the UAE import route in writing before dispatch; calculate it at arrival or clearance, whichever the authority applies.
- Compare the transport plan with the approved label and stability data. Confirm the permitted temperature range, protection from moisture and light, sealed secondary packaging, and data-logger records for any excursion.
- Reject a pack with altered artwork, unexplained temperature exposure, damaged seals, missing batch details or a shelf life below the agreed UAE threshold.
Qualify the Indian supplier and legalise the right documents
Do not release payment against a quotation alone. Obtain documents that connect the exporting company, legal manufacturer, product licence and shipped batch; a wholesaler invoice does not prove the supplier can export that particular medicine.
1. Ask for the manufacturer’s current licence, manufacturing-site GMP certificate, Certificate of Pharmaceutical Product or equivalent market-authorisation evidence, and free-sale certificate. Check that each names the same legal manufacturer, abiraterone acetate product, tablet strength and dosage form.
2. Request the product registration or marketing authorisation from India’s competent authority, plus a letter authorising the UAE importer or regulatory representative to represent the product. The letter must identify the UAE entity, manufacturer, brand, 250 mg or 500 mg strength and tablet form.
3. Obtain the batch-specific Certificate of Analysis before dispatch. It must show the shipped batch number, manufacturing and expiry dates, specifications, test results and approved pharmacopoeial or in-house methods. Request the quality-unit batch-release document as well; a CoA reports results but does not alone prove formal batch release.
4. Compare the supplier’s legal name, address and bank details with the manufacturer and export documents. If Cordium Pharmaceuticals Pvt Ltd is coordinating supply, ask it to identify whether it is the manufacturer, exporter or sourcing intermediary and provide the manufacturer’s evidence rather than relying on its quotation.
5. Confirm the UAE authority and import route’s legalisation instructions before paying. Arrange a certified Arabic translation where required, then obtain embassy attestation for the documents that route accepts; do not assume every certificate needs the same attestation chain. Verify acceptance with the UAE importer or authorised representative before dispatch.
Related products
![]() | Oncology Medicine Abiraquick 250mg Tablets – Abiraterone Acetate Abiraquick 250mg Tablets contain abiraterone acetate 250 mg, an anti-cancer medicine used in the management of certain forms of advanced prostate... View product → |
![]() | Oncology Medicine Product Overview Ahabir 250mg Tablet is a pharmaceutical formulation containing Abiraterone Acetate 250mg as its active pharmaceutical ingredient... View product → |
Frequently asked questions
Which import route should Dubai buyers confirm first?
Confirm the exact abiraterone acetate product, 250 mg or 500 mg strength, manufacturer and pack size. Then ask the UAE-licensed importer which authority will approve the medicine and which route applies.
What documents belong in the customs-clearance file?
Build a file containing the commercial invoice, packing list, transport document, certificate of origin and any customs documents requested by the importer or clearance agent.
What documents belong in the medicine-approval file?
Keep the product registration or approval records, manufacturer and supplier licences, certificate of pharmaceutical product, batch certificate, product artwork and other documents requested by the approving authority.
How should you reconcile the shipment before dispatch?
Compare the invoice, carton labels, blister packs and batch certificate for product name, strength, pack size, batch number, manufacturing date, expiry date and manufacturer identity.
What should you check on abiraterone acetate packaging and transport?
Check whether the artwork matches the approved product, confirm the requested 250 mg or 500 mg strength, verify remaining shelf life and obtain the required storage and transport temperature instructions.
Related products
![]() | Oncology Medicine Zybiraa 500mg Tablet in Dubai, UAE – Abiraterone Acetate 500mg Zybiraa 500mg Tablet contains Abiraterone Acetate 500mg, an oral medicine used as part of hormone-based treatment for certain forms of advanced... |
![]() | Oncology Medicine Ahabir 500mg Tablets – Abiraterone Acetate 500mg Ahabir 500mg Tablets contain Abiraterone Acetate 500mg, an androgen biosynthesis inhibitor used under medical supervision for the treatment of... View product → |
![]() | Oncology Medicine Xbira 250mg Tablets – Abiraterone Acetate 250mg for Prostate Cancer Treatment Product Overview Xbira 250mg Tablets contain abiraterone acetate 250mg, an oral prescription medicine used as part of treatment for certain types of... View product → |
![]() | Oncology Medicine Abirapro 150 mg Tablets – Abiraterone Acetate 150 mg Product Information Abirapro 150 mg Tablets contain abiraterone acetate 150 mg, an oral prescription medicine used as part of treatment for certain types of advanced... |












